Weighing the Benefits of Genetic Information in Clinical Psychiatry

Genetic information is slowly working its way into psychiatric practice and our patients’ daily lives. Pharmacogenomic panels can be ordered by psychiatrists, and genetic testing is being sold to the general public without any involvement of physicians or genetic counselors. The practicing psychiatrist needs to be informed about both of these types of services.

Genetic panels marketed to psychiatrists

When pharmacogenomic panels started to hit the market about 5 years ago, most general psychiatrists greeted this option with understandable skepticism. Now the use of these tests is growing, both in numbers of genes tested and in the number of psychiatrists utilizing them.

According to Daniel Dowd, PharmD, Vice President of Medical Affairs at Genomind, one of the two leading commercial pharmacogenomic services, close to 5000 clinicians are currently using Genomind’s panel, and the company has recently logged its 100,000th test. “What we’re actually seeing in practice is most psychiatrists are ordering this for the treatment-resistant patients with 2 or more treatment failures,” says Dr. Dowd. “But in the pediatric patient population, they’re more likely to order it for treatment-naive patients.”

John A. R. Grimaldi Jr, MD, Instructor at Harvard Medical School (HMS) and attending outpatient psychiatrist at Brigham and Women’s Hospital (BWH), says he has had many patients ask about these genetic panels, and 2 patients brought in genetic panels ordered by their previous psychiatrist. “There is a real need for guidance about the use of these ‘assays’,” says Dr. Grimaldi. “I can imagine that ‘genetic assays’ would be useful with treatment-resistant patients, if the assay were paid for by insurance and if there were an evidence base to support interpretation.”

As a new neuropsychiatry fellow, I started to use pharmacogenomic testing for some of my patients last year when I inherited and started to collect a patient caseload filled with…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *